 | • レポートコード：QYR9NV00154 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、アダリムマブバイオシミラーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、タブレット、経口液に、用途別には、病院薬局、小売薬局、オンライン薬局にセグメント区分し、アダリムマブバイオシミラーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・アダリムマブバイオシミラーの世界市場概要 ・アダリムマブバイオシミラーの製造コスト構成分析 ・アダリムマブバイオシミラーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・アダリムマブバイオシミラーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・アダリムマブバイオシミラーのセグメント分析（種類別） （タブレット、経口液） ・アダリムマブバイオシミラーのセグメント分析（用途別） （病院薬局、小売薬局、オンライン薬局） ・アダリムマブバイオシミラーの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （AET BioTech、Amgen、Boehringer Ingelheim、Coherus Biosciences、Fujifilm Kyowa Kirin Biologics、LG Life Sciences/Mochida Pharmaceutical、Momenta Pharmaceuticals、Oncobiologics、Pfizer、Samsung Bioepsis、Sandoz、Zydus Cadila、） ・アダリムマブバイオシミラーの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Adalimumab Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Adalimumab Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adalimumab Biosimilar market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Adalimumab Biosimilar in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Adalimumab Biosimilar manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tablet
Oral Solution
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Table of Contents
Executive Summary
1 Industry Overview of Adalimumab Biosimilar
1.1 Definition of Adalimumab Biosimilar
1.2 Adalimumab Biosimilar Segment by Type
1.2.1 Global Adalimumab Biosimilar Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Adalimumab Biosimilar Segment by Applications
1.3.1 Global Adalimumab Biosimilar Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Adalimumab Biosimilar Overall Market
1.4.1 Global Adalimumab Biosimilar Revenue (2014-2025)
1.4.2 Global Adalimumab Biosimilar Production (2014-2025)
1.4.3 North America Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.4 Europe Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.5 China Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.6 Japan Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.7 Southeast Asia Adalimumab Biosimilar Status and Prospect (2014-2025)
1.4.8 India Adalimumab Biosimilar Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Adalimumab Biosimilar
2.3 Manufacturing Process Analysis of Adalimumab Biosimilar
2.4 Industry Chain Structure of Adalimumab Biosimilar
3 Development and Manufacturing Plants Analysis of Adalimumab Biosimilar
3.1 Capacity and Commercial Production Date
3.2 Global Adalimumab Biosimilar Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Adalimumab Biosimilar
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Adalimumab Biosimilar Production and Capacity Analysis
4.2 Adalimumab Biosimilar Revenue Analysis
4.3 Adalimumab Biosimilar Price Analysis
4.4 Market Concentration Degree
5 Adalimumab Biosimilar Regional Market Analysis
5.1 Adalimumab Biosimilar Production by Regions
5.1.1 Global Adalimumab Biosimilar Production by Regions
5.1.2 Global Adalimumab Biosimilar Revenue by Regions
5.2 Adalimumab Biosimilar Consumption by Regions
5.3 North America Adalimumab Biosimilar Market Analysis
5.3.1 North America Adalimumab Biosimilar Production
5.3.2 North America Adalimumab Biosimilar Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Adalimumab Biosimilar Import and Export
5.4 Europe Adalimumab Biosimilar Market Analysis
5.4.1 Europe Adalimumab Biosimilar Production
5.4.2 Europe Adalimumab Biosimilar Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Adalimumab Biosimilar Import and Export
5.5 China Adalimumab Biosimilar Market Analysis
5.5.1 China Adalimumab Biosimilar Production
5.5.2 China Adalimumab Biosimilar Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Adalimumab Biosimilar Import and Export
5.6 Japan Adalimumab Biosimilar Market Analysis
5.6.1 Japan Adalimumab Biosimilar Production
5.6.2 Japan Adalimumab Biosimilar Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Adalimumab Biosimilar Import and Export
5.7 Southeast Asia Adalimumab Biosimilar Market Analysis
5.7.1 Southeast Asia Adalimumab Biosimilar Production
5.7.2 Southeast Asia Adalimumab Biosimilar Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Adalimumab Biosimilar Import and Export
5.8 India Adalimumab Biosimilar Market Analysis
5.8.1 India Adalimumab Biosimilar Production
5.8.2 India Adalimumab Biosimilar Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Adalimumab Biosimilar Import and Export
6 Adalimumab Biosimilar Segment Market Analysis (by Type)
6.1 Global Adalimumab Biosimilar Production by Type
6.2 Global Adalimumab Biosimilar Revenue by Type
6.3 Adalimumab Biosimilar Price by Type
7 Adalimumab Biosimilar Segment Market Analysis (by Application)
7.1 Global Adalimumab Biosimilar Consumption by Application
7.2 Global Adalimumab Biosimilar Consumption Market Share by Application (2014-2019)
8 Adalimumab Biosimilar Major Manufacturers Analysis
8.1 AET BioTech
8.1.1 AET BioTech Adalimumab Biosimilar Production Sites and Area Served
8.1.2 AET BioTech Product Introduction, Application and Specification
8.1.3 AET BioTech Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Amgen
8.2.1 Amgen Adalimumab Biosimilar Production Sites and Area Served
8.2.2 Amgen Product Introduction, Application and Specification
8.2.3 Amgen Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Adalimumab Biosimilar Production Sites and Area Served
8.3.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.3.3 Boehringer Ingelheim Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Coherus Biosciences
8.4.1 Coherus Biosciences Adalimumab Biosimilar Production Sites and Area Served
8.4.2 Coherus Biosciences Product Introduction, Application and Specification
8.4.3 Coherus Biosciences Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Fujifilm Kyowa Kirin Biologics
8.5.1 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Sites and Area Served
8.5.2 Fujifilm Kyowa Kirin Biologics Product Introduction, Application and Specification
8.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 LG Life Sciences/Mochida Pharmaceutical
8.6.1 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Sites and Area Served
8.6.2 LG Life Sciences/Mochida Pharmaceutical Product Introduction, Application and Specification
8.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Momenta Pharmaceuticals
8.7.1 Momenta Pharmaceuticals Adalimumab Biosimilar Production Sites and Area Served
8.7.2 Momenta Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Oncobiologics
8.8.1 Oncobiologics Adalimumab Biosimilar Production Sites and Area Served
8.8.2 Oncobiologics Product Introduction, Application and Specification
8.8.3 Oncobiologics Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Pfizer
8.9.1 Pfizer Adalimumab Biosimilar Production Sites and Area Served
8.9.2 Pfizer Product Introduction, Application and Specification
8.9.3 Pfizer Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Samsung Bioepsis
8.10.1 Samsung Bioepsis Adalimumab Biosimilar Production Sites and Area Served
8.10.2 Samsung Bioepsis Product Introduction, Application and Specification
8.10.3 Samsung Bioepsis Adalimumab Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Sandoz
8.12 Zydus Cadila
9 Development Trend of Analysis of Adalimumab Biosimilar Market
9.1 Global Adalimumab Biosimilar Market Trend Analysis
9.1.1 Global Adalimumab Biosimilar Market Size (Volume and Value) Forecast 2019-2025
9.2 Adalimumab Biosimilar Regional Market Trend
9.2.1 North America Adalimumab Biosimilar Forecast 2019-2025
9.2.2 Europe Adalimumab Biosimilar Forecast 2019-2025
9.2.3 China Adalimumab Biosimilar Forecast 2019-2025
9.2.4 Japan Adalimumab Biosimilar Forecast 2019-2025
9.2.5 Southeast Asia Adalimumab Biosimilar Forecast 2019-2025
9.2.6 India Adalimumab Biosimilar Forecast 2019-2025
9.3 Adalimumab Biosimilar Market Trend (Product Type)
9.4 Adalimumab Biosimilar Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Adalimumab Biosimilar Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Adalimumab Biosimilar
Table Global Adalimumab Biosimilar Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Adalimumab Biosimilar Production Market Share by Types in 2018
Figure Tablet Product Picture
Figure Oral Solution Product Picture
Table Global Adalimumab Biosimilar Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Adalimumab Biosimilar Consumption Market Share by Applications in 2018
Figure Hospital Pharmacy
Figure Retail Pharmacy
Figure Online Pharmacy
Figure Global Adalimumab Biosimilar Revenue (Million USD) (2014-2025)
Figure Global Adalimumab Biosimilar Production (K Units) (2014-2025)
Figure North America Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure Europe Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure China Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure Japan Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure Southeast Asia Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Figure India Adalimumab Biosimilar Market Size (Million USD) (2014-2025)
Table Adalimumab Biosimilar Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Adalimumab Biosimilar in 2018
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Industry Chain Structure of Adalimumab Biosimilar
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Adalimumab Biosimilar Manufacturing Plants Distribution
Table Adalimumab Biosimilar Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Adalimumab Biosimilar Capacity (K Units) of Major Manufacturers (2014-2019)
Table Adalimumab Biosimilar Production (K Units) of Major Manufacturers (2014-2019)
Table Adalimumab Biosimilar Production Market Share of Major Manufacturers (2014-2019)
Figure Adalimumab Biosimilar Production Share by Manufacturers in 2018
Table Adalimumab Biosimilar Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Adalimumab Biosimilar Revenue Market Share of Major Manufacturers (2014-2019)
Figure Adalimumab Biosimilar Revenue Share by Manufacturers in 2018
Table Adalimumab Biosimilar Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Adalimumab Biosimilar Production by Regions 2014-2019 (K Units)
Table Global Adalimumab Biosimilar Production Market Share by Regions 2014-2019
Figure Global Adalimumab Biosimilar Production Market Share by Regions in 2018
Table Global Adalimumab Biosimilar Revenue by Regions 2014-2019 (Million USD)
Table Global Adalimumab Biosimilar Revenue Market Share by Regions 2014-2019
Figure Global Adalimumab Biosimilar Revenue Market Share by Regions in 2018
Table Global Adalimumab Biosimilar Consumption by Regions 2014-2019 (K Units)
Table Global Adalimumab Biosimilar Consumption Market Share by Regions 2014-2019
Figure North America Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure North America Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table North America Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure Europe Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Europe Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure China Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure China Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table China Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure Japan Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Japan Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure Southeast Asia Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure India Adalimumab Biosimilar Production Growth Rate 2014-2019 (K Units)
Figure India Adalimumab Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table India Adalimumab Biosimilar Production, Consumption Import and Export (K Units)
Figure Global Consumption Adalimumab Biosimilar Market Share by Application (2014-2019)
Figure Global Value (Consumption) Adalimumab Biosimilar Market Share by Application (2014-2019)
Table AET BioTech Adalimumab Biosimilar Production Sites and Area Served
Table AET BioTech Adalimumab Biosimilar Product Introduction, Application and Specification
Table AET BioTech Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AET BioTech Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table AET BioTech Adalimumab Biosimilar Production Market Share (2014-2019)
Figure AET BioTech Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table AET BioTech Adalimumab Biosimilar Main Business and Markets Served
Table Amgen Adalimumab Biosimilar Production Sites and Area Served
Table Amgen Adalimumab Biosimilar Product Introduction, Application and Specification
Table Amgen Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Amgen Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Amgen Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Amgen Adalimumab Biosimilar Main Business and Markets Served
Table Boehringer Ingelheim Adalimumab Biosimilar Production Sites and Area Served
Table Boehringer Ingelheim Adalimumab Biosimilar Product Introduction, Application and Specification
Table Boehringer Ingelheim Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Boehringer Ingelheim Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Adalimumab Biosimilar Main Business and Markets Served
Table Coherus Biosciences Adalimumab Biosimilar Production Sites and Area Served
Table Coherus Biosciences Adalimumab Biosimilar Product Introduction, Application and Specification
Table Coherus Biosciences Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Coherus Biosciences Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Coherus Biosciences Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Coherus Biosciences Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Coherus Biosciences Adalimumab Biosimilar Main Business and Markets Served
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Sites and Area Served
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Product Introduction, Application and Specification
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Main Business and Markets Served
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Sites and Area Served
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Product Introduction, Application and Specification
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Market Share (2014-2019)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Main Business and Markets Served
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production Sites and Area Served
Table Momenta Pharmaceuticals Adalimumab Biosimilar Product Introduction, Application and Specification
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Main Business and Markets Served
Table Oncobiologics Adalimumab Biosimilar Production Sites and Area Served
Table Oncobiologics Adalimumab Biosimilar Product Introduction, Application and Specification
Table Oncobiologics Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Oncobiologics Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Oncobiologics Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Oncobiologics Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Oncobiologics Adalimumab Biosimilar Main Business and Markets Served
Table Pfizer Adalimumab Biosimilar Production Sites and Area Served
Table Pfizer Adalimumab Biosimilar Product Introduction, Application and Specification
Table Pfizer Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Pfizer Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Pfizer Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Pfizer Adalimumab Biosimilar Main Business and Markets Served
Table Samsung Bioepsis Adalimumab Biosimilar Production Sites and Area Served
Table Samsung Bioepsis Adalimumab Biosimilar Product Introduction, Application and Specification
Table Samsung Bioepsis Adalimumab Biosimilar Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Samsung Bioepsis Adalimumab Biosimilar Production Growth Rate (2014-2019)
Table Samsung Bioepsis Adalimumab Biosimilar Production Market Share (2014-2019)
Figure Samsung Bioepsis Adalimumab Biosimilar Revenue Market Share (2014-2019)
Table Samsung Bioepsis Adalimumab Biosimilar Main Business and Markets Served
Table Sandoz Adalimumab Biosimilar Production Sites and Area Served
Table Zydus Cadila Adalimumab Biosimilar Production Sites and Area Served
Figure Global Adalimumab Biosimilar Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Adalimumab Biosimilar Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Adalimumab Biosimilar Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Adalimumab Biosimilar Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Adalimumab Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Adalimumab Biosimilar by Type (2019-2025)
Table Global Consumption (K Units) of Adalimumab Biosimilar by Application (2019-2025)
Table Adalimumab Biosimilar Distributors List
Table Adalimumab Biosimilar Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
バイオシミラーモノクローナル抗体の世界市場予測 2023年：メーカー別、地域別、種類・用途別 A monoclonal antibody is a type of protein made in the laboratory that can bind to substances in the body, including cancer cells. A monoclonal antibody is made so that it binds to only one substance to treat different types of cancer. There are several types of monoclonal antibodies that are being …- バイオシミラーモノクローナル抗体の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Scope of the Report: This report studies the Biosimilar Monoclonal Antibody market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimilar Monoclonal Antibody…
- ヒレセプチンバイオシミラーのグローバル市場調査 2019年 The global Hereceptin Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hereceptin Biosimilar volume and value at global level, regional level and company level. From a global perspective, …
- 神経バイオシミラー生物製剤のグローバル市場調査 2019年 The global Nerve Biosimilar Biological Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nerve Biosimilar Biological Products volume and value at global level, regional level and company leve…
- インターフェロンアルファ-2bバイオシミラーのグローバル市場調査 2019年 The global Interferon Alpha-2b Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interferon Alpha-2b Biosimilar volume and value at global level, regional level and company level. From a gl…